Total raised
—
Last: Undisclosed 2023-04
Stage
Seed
Founded
2020
Headcount
3
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
101 Therapeutics has developed the first-ever targeted glucocorticoid with all of the potency of steroids and none of the systemic toxicities. By targeting the host immune system rather than the pathogen itself, the company can effectively treat a multitude of infectious diseases, whether viral, parasitic, or bacterial.
Funding history · 1 round · — total
2023-04
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
biotechnologypharmaceuticalsinfectious-diseasedrug-developmentdrug-discovery